In other countries
The same active substances on other registers, the same brand first.
- BeyfortusBrazil · Sanofi Medley Farmacêutica Ltda.Same brand
- BeyfortusCanada · 50 MG / 0.5 ML · Solution · Sanofi Vaccines Canada LTD.Same brand
- BeyfortusCanada · 100 MG / 1 ML · Solution · Sanofi Vaccines Canada LTD.Same brand
- Beyfortus 100 MG Solucion Inyectable en Jeringa PrecargadaSpain · 100 mg · solución inyectable en jeringa precargada · Sanofi Winthrop IndustrieSame brand
- Beyfortus 50 MG Solucion Inyectable en Jeringa PrecargadaSpain · 100 mg · solución inyectable en jeringa precargada · Sanofi Winthrop IndustrieSame brand
- BeyfortusEuropean Union · Sanofi Winthrop IndustrieSame brand
- BeyfortusItaly · Soluzione iniettabile in siringa pre-riempita · Sanofi Winthrop IndustrieSame brand
- Beyfortus 100 mg, oplossing voor injectie in een voorgevulde spuitNetherlands · Oplossing voor injectie · Sanofi Winthrop IndustrieSame brand
- Beyfortus 50 mg, oplossing voor injectie in een voorgevulde spuitNetherlands · Oplossing voor injectie · Sanofi Winthrop IndustrieSame brand
- Beyfortus Solution for Injection in Pre-Filled Syringe 100 MG/ 1.0 MLSingapore · 100 mg / 1.0 mL · injection, solution · Sanofi-Aventis Singapore Pte. LTD.Same brand
- Beyfortus Solution for Injection in Pre-Filled Syringe 50 MG/ 0.5 MLSingapore · 50 mg/ 0.5 mL · injection, solution · Sanofi-Aventis Singapore Pte. LTD.Same brand
- BeyfortusUnited States · 100MG, 50MG · injectable · Astrazeneca ABSame brand
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
HALMED — Agencija za lijekove i medicinske proizvode RH
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH NN 67/2017 · Added 8 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Nirsevimab
- Register
- Croatia (HALMED)
- Status
- Authorised
- Registration
- 16747
- ATC code
- J06BD08
- Procedure
- EU centralised
- Supply
- na recept; u ljekarni